Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Acquisitions (2021 - 2022)

Bioventus' Acquisitions history spans 2 years, with the latest figure at $104.6 million for Q4 2022.

  • For Q4 2022, Acquisitions rose 328.46% year-over-year to $104.6 million; the TTM value through Oct 2022 reached $367.7 million, changed N/A, while the annual FY2021 figure was $262.9 million, N/A changed from the prior year.
  • Acquisitions reached $104.6 million in Q4 2022 per BVS's latest filing, up from -$5000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $262.9 million in Q4 2021 to a low of -$45.8 million in Q4 2021.